Monsanto (MON) : Valuation and Ethics of BioEngineering Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Non-Tech : Monsanto (MON) : Valuation and Ethics of BioEngineering

MON 127.95

0.0%

Jun 8 5:00 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

From: Jcarterwil	11/13/2017 10:01:57 PM
	of 40

Holganix has new research that suggests it can use probiotics to curtail Nematodes. Nematodes do about 100B in damage each year. Robert Fraley, CTO of Monsanto, recently stated that "nematodes are the greatest unsolved problem that farmers face in almost all their crops." Recent trial data from the labs of Dr. Kris Lambert at the University of Illinois supports that Holganix’ organic plant / soil probiotic is a cost effective solution to control nematodes. In addition to its action as a bio-nematicide, Holganix has been validated in commercial and university trials across over 20 crops (row and specialty produce) to increase yield and reduce inputs (water, fertilizer and other chemicals). The 800+ beneficial microbes in Holganix provide multiple modes of action to increase nutrient uptake (nitrogen, phosphorus, and potassium) by the plant, fight pests and disease, improve plant health and vigor, improve soil health, and reduce erosion and fertilizer run-off. Holganix Tackles Nematodes

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next